Thomas Striepe serves as Executive at SANGUI BIOTECH INTERNATIONAL INC, where they oversee executive responsibilities. Since joining the company, Thomas Striepe has executed 3 insider transactions totaling $13.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 23, 2012 involved receiving (via award) 750,000 shares valued at $435.0K.
Thomas Striepe currently holds 1,350,000 shares of SANGUI BIOTECH INTERNATIONAL INC (SGBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Striepe has been a net buyer of SGBI stock. They have purchased $13.0K and sold $0 worth of shares.
Thomas Striepe's most recent insider trade was on Apr 23, 2012, when they sold 750,000 shares at $0.58 per share.
Get notified when new Form 4 filings are submitted
| $0.13 |
| Discretionary |
| Apr 30, 2010 | SGBI | $13.0K | Purchase | 100,000 | $0.13 | Discretionary |